Search - tctmd.com

Displaying 161 - 180 of 264

Sort: Relevancy | Date

News Daily News

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

October 15, 2013

News Daily News

在使用DES接受PCI治疗的患者中，西洛他唑与双倍剂量氯吡格雷一样安全

Yael L. Maxwell

September 20, 2013

News Daily News

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Yael L. Maxwell

September 20, 2013

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

News Daily News

ISAR-LEFT MAIN 2试验：第二代DES治疗冠状动脉左主干疾病疗效相近

Yael L. Maxwell

September 13, 2013

News Daily News

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

Yael L. Maxwell

September 13, 2013

News Daily News

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Yael L. Maxwell

September 13, 2013

News Conference News ESC 2013

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

Yael L. Maxwell

September 02, 2013

News Daily News

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

L.A. McKeown

August 19, 2013

News Daily News

Meta Análisis: Los SLF son Más Eficaces que los SMD para los cuadros de STEMI Sin Compensación de la Seguridad

L.A. McKeown

August 19, 2013

Presentation

Clinical Outcomes of the Resolute ZES in Patients With In-Stent Restenosis

Presenter: Gert Richardt

August 14, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Daily News

Los SLS Sacan Ventaja a los SLZ y SLP en Pacientes Diabéticos

Yael L. Maxwell

June 20, 2013

News Industry News

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

May 22, 2013

News Industry News

Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United States

May 08, 2013

News Daily News

TWENTE: Still Few Differences between ZES and EES at 2 Years

L.A. McKeown

May 03, 2013

News Daily News

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

L.A. McKeown

May 03, 2013

News Daily News

La Revascularización Coronaria Híbrida es Prometedora para Pacientes de Alto Riesgo

Yael L. Maxwell

April 26, 2013

News Daily News

Hybrid Coronary Revascularization Shows Promise for High-Risk Patients

Yael L. Maxwell

April 26, 2013

Advertisement

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

在使用DES接受PCI治疗的患者中，西洛他唑与双倍剂量氯吡格雷一样安全

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

ISAR-LEFT MAIN 2试验：第二代DES治疗冠状动脉左主干疾病疗效相近

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

Meta-analysis: DES More Effective Than BMS for STEMI with No Safety Trade-off

Meta Análisis: Los SLF son Más Eficaces que los SMD para los cuadros de STEMI Sin Compensación de la Seguridad

Clinical Outcomes of the Resolute ZES in Patients With In-Stent Restenosis

Contemporary ZES Perform Well in Treating In-Stent Restenosis

SES Show Advantage Over ZES, PES for Diabetic Patients

Los SLS Sacan Ventaja a los SLZ y SLP en Pacientes Diabéticos

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results

Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United States

TWENTE: Still Few Differences between ZES and EES at 2 Years

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

La Revascularización Coronaria Híbrida es Prometedora para Pacientes de Alto Riesgo

Hybrid Coronary Revascularization Shows Promise for High-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content